Emergency icon Important Updates

Serpil Erzurum, MD

Serpil Erzurum, MD
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Inflammation and Immunity
Primary Location Cleveland Clinic Main Campus
Type of Doctor Both Adults and Children & Adolescents, Researcher
Languages English
Surgeon No
Locations Specialties & Treatments

Treatment & Services

  • Cancer Center
  • Lung Biology
  • Lung Physiology
  • Treating Asthma with Bronchodilators
View all 4 Treatment & Services +

Specialty in Diseases & Conditions

  • Asthma
  • Exhaled Markers in Lung Disease
  • Pulmonary Hypertension
View all 3 Specialties +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Serpil Erzurum, MD

Serpil Erzurum, MD, was named Chief Research and Academic Officer of Cleveland Clinic in 2020, representing an expansion of her prior role as Chair of the Lerner Research Institute, which she held since 2016. In her new role, Dr. Erzurum focuses on strategic growth of enterprise-wide medical and scientific education programs; clinical, basic and translational research; and technology development to deliver the most innovative care to patients.

A practicing pulmonologist and active scientist, Dr. Erzurum holds the Alfred Lerner Memorial Chair in Innovative Biomedical Research. Her scientific contributions and leadership in pulmonary research have led to diagnostic and therapeutic advances in lung diseases and helped to identify human physiologic adaptive responses to high-altitude hypoxia. She has published more than 300 peer-reviewed articles and has been the principal investigator on more than 20 federal grants, including multi-investigator program project grants and network trials. She is also a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Dr. Erzurum has earned numerous awards, including the prestigious MERIT award from the National Heart, Lung and Blood Institute (NHLBI). She was elected to the National Academy of Medicine (NAM), American Society for Clinical Investigation (ASCI), and Association of American Physicians (AAP), where she served as president from 2017-2018. She has also served as chair of the Pulmonary Disease Board of the American Board of Internal Medicine (ABIM). Because of her work in advancing the careers of women in medicine and science, Dr. Erzurum was honored with the Elizabeth Rich Award from the American Thoracic Society.

Dr. Erzurum earned her medical degree from Northeastern Ohio Universities College of Medicine and completed residency training in internal medicine at Baylor College of Medicine. She completed fellowship training at the University of Colorado Health Sciences Center and postdoctoral training at the National Heart, Lung and Blood Institute in Bethesda, Maryland.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - National Heart, Lung and Blood Institute
Senior Staff Fellow, Pulmonary
Bethesda, MD USA

Fellowship - University of Colorado Health Sciences Center
Pulmonary/Critical Care
Denver, CO USA

Residency - Baylor College of Medicine
Internal Medicine
Houston, TX USA

Medical Education - Northeastern Ohio Universities College of Medicine
Rootstown, OH USA

Additional Training

  • Certifications:

    Internal Medicine
  • Internal Medicine- Pulmonary Disease
  • Internal Medicine- Critical Care Medicine

Professional Highlights

  • Alfred Lerner Memorial Chair in Innovation Biomedical Research, Pathobiology Department, Lerner Research Institute, Cleveland Clinic
  • Chair, Allergy, Immunology, and Inflammation, American Thoracic Society (ATS)


  • Internal Medicine - Pulmonary Disease
  • Internal Medicine
  • Internal Medicine - Critical Care Medicine

Specialty Interests

Asthma, exhaled markers in lung disease, lung biology and physiology, pulmonary hypertension, nitric oxide (NO) in lung physiology and disease

Awards & Honors

  • The Elizabeth Rich Award in recognition for efforts on behalf of women in the American Thoracic Society.
  • Association of American Physicians (AAP), Elected Member
  • American Society For Clinical Investigation (ASCI), Elected Member
  • Henry D. McIntosh Outstanding Resident Award, Department Of Internal Medicine, Baylor College of Medicine¬†

Innovations & Patents


  • Deputy Editor, American Journal of Respiratory and Critical Care Medicine
  • Chair, American Board of Internal Medicine Pulmonary Disease Board, for the national certifying examination in pulmonary medicine
  • Scientific Leadership Council, Pulmonary Hypertension Association
Research & Publications

Research & Publications

See publications for Serpil Erzurum, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/3/2023, Dr. Erzurum has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top